This item may be available in a different size, colour, scent, version or platform:
Rx Sorbo Sorbothane Classic Insole (Male - 11-12)
The leading performance ultra-thin replacement insole featuring 100% Sorbothane coverage for outstanding foot-strike protection. They are so effective that they have been approved and recommended by the American Podiatric Medical Association. The Classic Running Shoe insole works well in all types of shoes and for all types of activities and sports. These ultra-thin shoe insoles fit perfectly into tight spaces in dress shoes, soccer cleats, golf shoes, baseball cleats and running spikes. Sorbothane is the only insole material that absorbs up to 94.7% of impact shock; and unlike standard insoles, which can bottom out, compress, and lose effectiveness, Sorbothane Classic Running Shoe Insoles retain their support and comfort month after month. Sorbothane rubber was developed to simulate the soft padding of the heel. This makes it the most comfortable and best cushioning insole rubber available. Unlike foam rubbers, it resists becoming hard or flat over time and lasts much longer than other insoles. RxSorbo insoles are proudly made in the USA at our factory in Kent, OH. For more information please visit www.rxsorbo.com.
So why exactly are RxSorbo shoe insoles MORE THAN JUST INSOLES? The main reason: they are NOT made of simple, gimmicky foam or gel like most insoles. They are made of an advanced VISCO-ELASTIC material called Sorbothane. Sorbothane is the leader in vibration isolation. It is the same material trusted by NASA, NASCAR, and countless other agencies and companies for their vibration isolation needs. RxSorbo insoles are recommended by Dr. Mark Mendeszoon. Dr. Mendeszoon is a Board Certified podiatrist who treats all types of surgical and non-surgical conditions of the leg, foot and ankle. He has trained athletes from the high school level up to current Olympic medalists.
"The Classic - 100% RxSorbo Insert helps to protect the entire body against impact related pain and injury." - Dr. Mark Mendeszoon